Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118309
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118309
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118309
Table 3 Summary of management strategies of rhabdomyolysis-associated acute kidney injury
| Management therapy | Recommendation |
| Fluid resuscitation | Early initiation; use crystalloids (lactated Ringer’s or normal saline); volume of 6 L/day or more |
| Bicarbonate, mannitol and antioxidant use | Based on clinician’s judgement; limited evidence with little difference in outcomes |
| Monitoring | Electrolyte imbalances: Hyperkalemia, hyperphosphatemia, hypocalcemia, hypomagnesemia; hemodynamic monitoring: Mean arterial pressure, renal perfusion pressure |
| Diuretics | Not necessary, except in fluid overload |
- Citation: Wong FHA, See KC. Critical care considerations in rhabdomyolysis-associated acute kidney injury and kidney replacement therapy. World J Nephrol 2026; 15(2): 118309
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/118309.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.118309